Dr. Michael Wang is a pediatric hematologist, who is dedicated to advancing clinical coagulation, by leading a multidisciplinary team that focuses our advancing knowledge and innovation on caring for patients with bleeding and clotting disorders.He completed medical training at the University of Rochester, residency at the University of Utah, and fellowship at the University of Colorado, where is currently a faculty member. As Clinical Director of University of Colorado Hemophilia & Thrombosis Center (HTC), he combines clinical care, healthcare delivery improvement, patient engagement, clinical trials,and teaching,to improve the lives of our patients throughout their entire lifespan.The University of Colorado HTC has an established clinical research program that spans the breadth of local, national and international investigator-initiated research,national and international disease specific registries, local and national patient reported clinical outcome trials,to leadership in industry-sponsored multi center Phase I-IV clinical trials evaluating both pro-and anti-coagulant strategies and patient reported clinical outcomes.